Alkermes to Host Conference Call to Discuss Third Quarter 2020 Financial Results
Alkermes plc (Nasdaq: ALKS) will hold a conference call and webcast on October 29, 2020, at 8:00 a.m. ET to discuss its third quarter 2020 financial results and provide updates on company performance.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alkermes plc (Nasdaq: ALKS) will hold a conference call and webcast on October 29, 2020, at 8:00 a.m. ET to discuss its third quarter 2020 financial results and provide updates on company performance. The event will be accessible via the company's website. A replay will be available starting at 11:00 a.m. ET on the same day, lasting until November 5, 2020. Alkermes focuses on innovative medicines in neuroscience and oncology, featuring a pipeline for treatments in addiction, schizophrenia, and cancer.
Positive
- Company will provide updates on third quarter 2020 financial results.
- Focus on innovative medicines in neuroscience and oncology.
Negative
- None.
Details
News Market Reaction – ALKS
The recorded move for ALKS in the trading session of this news was +0.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DUBLIN, Oct. 22, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m. GMT) on Thursday, Oct. 29, 2020 to discuss the company's third quarter 2020 financial results. Management will also provide an update on the company.
The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers.
A replay of the conference call will be available from 11:00 a.m. ET (3:00 p.m. GMT) on Thursday, Oct. 29, 2020, through Thursday Nov. 5, 2020, and may be accessed by visiting Alkermes' website or by dialing +1 877 660 6853 for U.S. callers and +1 201 612 7415 for international callers. The replay access code is 13712082.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-to-host-conference-call-to-discuss-third-quarter-2020-financial-results-301158333.html
SOURCE Alkermes plc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.